Once a day galantamine pharmaceutical compositions and methods of use

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20040097484A1
SERIAL NO

10293942

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are once a day pharmaceutical compositions containing acetylcholinesterase inhibitors, including those with nicotinic receptor modulation such as galantamine or a pharmaceutically acceptable salt thereof Also disclosed is the use of such compositions, for example, for treating or preventing cognitive or other CNS performance impairment in a mammal, such as primary or secondary memory impairment, toxic, secondary to medical or psychiatric, Alzheimer's, vascular and other dementias, mild cognitive impairments, and other cognitive impairments, such as Attention Deficit Disorder, Fibromyalgia, Chronic Fatigue Syndrome, PTSD and Down's Syndrome. This includes behavioral efficacy, as anxiety depression apathy and agitation, in addition to neurophysiological and functional outcomes including a decrease in care givers distress.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
IMPAX LABORATORIES INC30831 HUNTWOOD AVENUE HAYWARD CA 94544

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cantillion, Marc San Francisco, CA 1 18
Han, Chien-Hsuan Hayward, CA 21 703
Hsu, Ann Hayward, CA 24 347

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation